Enanta Pharmaceuticals
ENTA
ENTA
149 hedge funds and large institutions have $447M invested in Enanta Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 57 increasing their positions, 39 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
29% more capital invested
Capital invested by funds: $347M → $447M (+$99.7M)
10% more funds holding
Funds holding: 136 → 149 (+13)
Holders
149
Holding in Top 10
4
Calls
$492K
Puts
–
Top Buyers
| 1 | +$10.4M | |
| 2 | +$7.94M | |
| 3 | +$7.77M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$6.68M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$5.14M |
Top Sellers
| 1 | -$13.5M | |
| 2 | -$6.9M | |
| 3 | -$6.65M | |
| 4 |
SIM
Spark Investment Management
New York
|
-$4.28M |
| 5 |
Renaissance Technologies
New York
|
-$4.24M |